Analysis of B Cell Differentiation in Multiple Sclerosis

CompletedNot a drug-phase studyEarly (CIS/RIS)NCT03744351

We could not find results for this trial

What it found

No results found

We found no results in the registry or in papers.

This trial finished 3 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • Biological Samples

What it measured

Main measures

  • Plasmablasts frequency

    At Day 6 after differentiation of B cells

    Immune response

Who could take part

Early (CIS/RIS) · 18 and over

Show the full criteria

Inclusion criteria

Regarding MS patients (remitting or progressive untreated): * Adult (age greater than or equal to 18 years) of both sexes; * MS fulfilling the criteria of McDonald 2017; * Remittent or progressive form; * No immunomodulatory or immunosuppressive therapy for at least 3 months; * Free, informed and written consent signed by the patient. Regarding Clinically Isolated Syndrome: * Adult (age greater than or equal to 18 years) of both sexes; * Clinically isolated syndrome suggestive of MS (at least two typical lesions in two different locations); * Patient receiving a Lumbar Puncture (PL) for diagnostic purposes; * No immunomodulatory or immunosuppressive therapy for at least 3 months; * Free, informed and written consent signed by the patient. Regarding non-MS patients with neurological inflammatory disease: * Adult (age greater than or equal to 18 years) of both sexes; * Patient with non-MS neurological inflammatory disease (examples: meningitis, neurolupus, neurosarcoidosis...); * Patients with PL for diagnostic or surveillance purposes; * No immunomodulatory or immunosuppressive therapy for at least 3 months; * Free, informed and written consent signed by the patient. Regarding healthy volunteers: * Adult (age greater than or equal to 18 years) of both sexes; * Free, informed and written consent signed by the volunteer.

Exclusion criteria

Regarding all patients: * Pregnancy; * Breastfeeding; * Treatment with corticotherapy in the last month; * Patient not affiliated to social security; * Persons major subject to legal protection (safeguard of justice, guardianship, tutorship), persons deprived of their liberty. Regarding healthy volunteers: * Pregnancy; * Breastfeeding; * Not affiliated to social security; * Persons major subject to legal protection (safeguard of justice, guardianship, tutorship), persons deprived of their liberty.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Interventional study with minimal risks and constraints, prospective, monocentric.

Papers

    Loading reviews and guidelines…

    Linked trials

    Links found where a registry record names another trial's registry number.

    History

      1. Started

        Feb 2019

      2. Main results due

        May 2023

      3. Finished

        May 2023

      Assembled by software from public sources.